| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
75,461 |
68,283 |
$16.76M |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
90,922 |
79,416 |
$12.76M |
| A0425 |
Ground mileage, per statute mile |
219,450 |
180,972 |
$11.89M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
42,522 |
38,824 |
$6.58M |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
9,218 |
8,875 |
$2.09M |
| A0434 |
Specialty care transport (sct) |
1,107 |
984 |
$165K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
178 |
122 |
$55K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
97 |
79 |
$53K |
| A0998 |
Ambulance response and treatment, no transport |
228 |
216 |
$44K |
| A0433 |
Advanced life support, level 2 (als 2) |
123 |
123 |
$38K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
74 |
48 |
$21K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
54 |
34 |
$14K |
| A0422 |
Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation |
241 |
140 |
$0.00 |